Pre-treatment clinical features in central retinal vein occlusion that predict visual outcome following intravitreal ranibizumab

Pre-treatment clinical features in central retinal vein occlusion that predict visual outcome following intravitreal ranibizumab

Abstract Background Predicting how patients with central retinal vein occlusion (CRVO) will respond to intravitreal anti-VEGF is challenging. The purpose of this study was to identify pre-treatment clinical features in CRVO that predict visual acuity (VA) following intravitreal ranibizumab. Methods...

Full description

Bibliographic Details
Main Authors: Kerr Brogan, Monica Precup, Amanda Rodger, David Young, David Francis Gilmour
Format: Article
Language:English
Published: BMC 2018-02-01
Series:BMC Ophthalmology
Subjects:
Retina
Central retinal vein occlusion
Anti-VEGF
Ranibuzimab
Online Access:http://link.springer.com/article/10.1186/s12886-018-0701-x

Internet

http://link.springer.com/article/10.1186/s12886-018-0701-x

Similar Items